questionsmedicales.fr
Hémopathies et maladies lymphatiques
Hémopathies
Maladies de la moelle osseuse
Maladies de la moelle osseuse : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Biopsie de la moelle osseuse
Anémie
Leucémie
Aspirations de moelle osseuse
Tests génétiques
Hématologie
Fatigue
Infections
Saignements
Imagerie par résonance magnétique
Tomodensitométrie
Moelle osseuse
Tests sanguins
Anomalies sanguines
Hématologie
Symptômes
5
Fatigue
Fièvre
Douleurs osseuses
Système immunitaire
Globules blancs
Immunodéficience
Saignements
Plaquettes
Hémorragie
Douleurs osseuses
Infiltration
Cellules anormales
Types de maladies
Symptômes
Hématologie
Prévention
5
Prévention
Mode de vie sain
Hérédité
Facteurs de risque
Produits chimiques
Toxiques
Alimentation
Santé
Moelle osseuse
Tabagisme
Facteurs de risque
Maladies hématologiques
Examens réguliers
Prévention
Anomalies
Traitements
5
Chimiothérapie
Radiothérapie
Greffe de moelle osseuse
Greffe de moelle osseuse
Efficacité
Risques
Médicaments
Immunosuppresseurs
Facteurs de croissance
Radiothérapie
Cancer
Moelle osseuse
Traitements personnalisés
Type de maladie
Gravité
Complications
5
Complications
Infections
Insuffisance médullaire
Cancer
Risque
Maladies de la moelle osseuse
Infections
Immunodéficience
Moelle osseuse
Saignements
Plaquettes
Graves
Insuffisance médullaire
Anémie
Hémorragies
Facteurs de risque
5
Facteurs de risque
Radiations
Antécédents familiaux
Âge
Risque
Maladies de la moelle
Maladies auto-immunes
Risque
Moelle osseuse
Mode de vie
Tabagisme
Risque
Infections virales
VIH
Risque
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Maladies de la moelle osseuse : Questions médicales les plus fréquentes",
"headline": "Maladies de la moelle osseuse : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Maladies de la moelle osseuse : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-15",
"dateModified": "2025-04-10",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Maladies de la moelle osseuse"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Hémopathies",
"url": "https://questionsmedicales.fr/mesh/D006402",
"about": {
"@type": "MedicalCondition",
"name": "Hémopathies",
"code": {
"@type": "MedicalCode",
"code": "D006402",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C15.378"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Aplasies médullaires",
"alternateName": "Bone Marrow Failure Disorders",
"url": "https://questionsmedicales.fr/mesh/D000080983",
"about": {
"@type": "MedicalCondition",
"name": "Aplasies médullaires",
"code": {
"@type": "MedicalCode",
"code": "D000080983",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C15.378.190.223"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Anémie aplasique",
"alternateName": "Anemia, Aplastic",
"url": "https://questionsmedicales.fr/mesh/D000741",
"about": {
"@type": "MedicalCondition",
"name": "Anémie aplasique",
"code": {
"@type": "MedicalCode",
"code": "D000741",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C15.378.190.223.250"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Maladies myélodysplasiques-myéloprolifératives",
"alternateName": "Myelodysplastic-Myeloproliferative Diseases",
"url": "https://questionsmedicales.fr/mesh/D054437",
"about": {
"@type": "MedicalCondition",
"name": "Maladies myélodysplasiques-myéloprolifératives",
"code": {
"@type": "MedicalCode",
"code": "D054437",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C15.378.190.615"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Leucémie myélomonocytaire juvénile",
"alternateName": "Leukemia, Myelomonocytic, Juvenile",
"url": "https://questionsmedicales.fr/mesh/D054429",
"about": {
"@type": "MedicalCondition",
"name": "Leucémie myélomonocytaire juvénile",
"code": {
"@type": "MedicalCode",
"code": "D054429",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C15.378.190.615.520"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Syndromes myélodysplasiques",
"alternateName": "Myelodysplastic Syndromes",
"url": "https://questionsmedicales.fr/mesh/D009190",
"about": {
"@type": "MedicalCondition",
"name": "Syndromes myélodysplasiques",
"code": {
"@type": "MedicalCode",
"code": "D009190",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C15.378.190.625"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Anémie réfractaire",
"alternateName": "Anemia, Refractory",
"url": "https://questionsmedicales.fr/mesh/D000753",
"about": {
"@type": "MedicalCondition",
"name": "Anémie réfractaire",
"code": {
"@type": "MedicalCode",
"code": "D000753",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C15.378.190.625.062"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Anémie réfractaire avec excès de blastes",
"alternateName": "Anemia, Refractory, with Excess of Blasts",
"url": "https://questionsmedicales.fr/mesh/D000754",
"about": {
"@type": "MedicalCondition",
"name": "Anémie réfractaire avec excès de blastes",
"code": {
"@type": "MedicalCode",
"code": "D000754",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C15.378.190.625.062.080"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Anémie réfractaire avec excès de blastes",
"alternateName": "Anemia, Refractory, with Excess of Blasts",
"url": "https://questionsmedicales.fr/mesh/D000754",
"about": {
"@type": "MedicalCondition",
"name": "Anémie réfractaire avec excès de blastes",
"code": {
"@type": "MedicalCode",
"code": "D000754",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C15.378.190.625.062.080"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Anémie sidéroblastique",
"alternateName": "Anemia, Sideroblastic",
"url": "https://questionsmedicales.fr/mesh/D000756",
"about": {
"@type": "MedicalCondition",
"name": "Anémie sidéroblastique",
"code": {
"@type": "MedicalCode",
"code": "D000756",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C15.378.190.625.070"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Hémoglobinurie paroxystique",
"alternateName": "Hemoglobinuria, Paroxysmal",
"url": "https://questionsmedicales.fr/mesh/D006457",
"about": {
"@type": "MedicalCondition",
"name": "Hémoglobinurie paroxystique",
"code": {
"@type": "MedicalCode",
"code": "D006457",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C15.378.190.625.460"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Syndromes myéloprolifératifs",
"alternateName": "Myeloproliferative Disorders",
"url": "https://questionsmedicales.fr/mesh/D009196",
"about": {
"@type": "MedicalCondition",
"name": "Syndromes myéloprolifératifs",
"code": {
"@type": "MedicalCode",
"code": "D009196",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C15.378.190.636"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Anémie myélophtisique",
"alternateName": "Anemia, Myelophthisic",
"url": "https://questionsmedicales.fr/mesh/D000750",
"about": {
"@type": "MedicalCondition",
"name": "Anémie myélophtisique",
"code": {
"@type": "MedicalCode",
"code": "D000750",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C15.378.190.636.085"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Leucémie érythroblastique aigüe",
"alternateName": "Leukemia, Erythroblastic, Acute",
"url": "https://questionsmedicales.fr/mesh/D004915",
"about": {
"@type": "MedicalCondition",
"name": "Leucémie érythroblastique aigüe",
"code": {
"@type": "MedicalCode",
"code": "D004915",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C15.378.190.636.276"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Myélofibrose primitive",
"alternateName": "Primary Myelofibrosis",
"url": "https://questionsmedicales.fr/mesh/D055728",
"about": {
"@type": "MedicalCondition",
"name": "Myélofibrose primitive",
"code": {
"@type": "MedicalCode",
"code": "D055728",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C15.378.190.636.765"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Thrombocytose",
"alternateName": "Thrombocytosis",
"url": "https://questionsmedicales.fr/mesh/D013922",
"about": {
"@type": "MedicalCondition",
"name": "Thrombocytose",
"code": {
"@type": "MedicalCode",
"code": "D013922",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C15.378.190.636.860"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Maladies de la moelle osseuse",
"alternateName": "Bone Marrow Diseases",
"code": {
"@type": "MedicalCode",
"code": "D001855",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Sebastian Berg",
"url": "https://questionsmedicales.fr/author/Sebastian%20Berg",
"affiliation": {
"@type": "Organization",
"name": "Division of Pediatric Radiology, Department of Radiology, University Medical Center Freiburg, University of Freiburg, Freiburg, Germany."
}
},
{
"@type": "Person",
"name": "Charlotte Niemeyer",
"url": "https://questionsmedicales.fr/author/Charlotte%20Niemeyer",
"affiliation": {
"@type": "Organization",
"name": "Division of Pediatric Hematology and Oncology, Department of Pediatric and Adolescent Medicine, University Medical Center Freiburg, University of Freiburg, Freiburg, Germany."
}
},
{
"@type": "Person",
"name": "Ioannis Mitroulis",
"url": "https://questionsmedicales.fr/author/Ioannis%20Mitroulis",
"affiliation": {
"@type": "Organization",
"name": "Institute for Clinical Chemistry and Laboratory Medicine, University Hospital and Faculty of Medicine Carl Gustav Carus of TU Dresden, Germany (I.M., T.C.)."
}
},
{
"@type": "Person",
"name": "George Hajishengallis",
"url": "https://questionsmedicales.fr/author/George%20Hajishengallis",
"affiliation": {
"@type": "Organization",
"name": "Laboratory of Innate Immunity and Inflammation, Department of Basic and Translational Sciences, Penn Dental Medicine, University of Pennsylvania, Philadelphia (G.H.)."
}
},
{
"@type": "Person",
"name": "Triantafyllos Chavakis",
"url": "https://questionsmedicales.fr/author/Triantafyllos%20Chavakis",
"affiliation": {
"@type": "Organization",
"name": "Institute for Clinical Chemistry and Laboratory Medicine, University Hospital and Faculty of Medicine Carl Gustav Carus of TU Dresden, Germany (I.M., T.C.)."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Evaluation of bone mineral density and bone turnover in children on anticoagulation.",
"datePublished": "2023-08-01",
"url": "https://questionsmedicales.fr/article/37600706",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fendo.2023.1192670"
}
},
{
"@type": "ScholarlyArticle",
"name": "Intraoperative physician assessment of bone: correlation to bone mineral density.",
"datePublished": "2023-03-31",
"url": "https://questionsmedicales.fr/article/37000208",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00198-023-06729-3"
}
},
{
"@type": "ScholarlyArticle",
"name": "Influence of bone density on stability in TBW.",
"datePublished": "2023-11-15",
"url": "https://questionsmedicales.fr/article/37968632",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12891-023-07007-3"
}
},
{
"@type": "ScholarlyArticle",
"name": "[Bone mineral density in vegetarians and vegans].",
"datePublished": "2023-04-17",
"url": "https://questionsmedicales.fr/article/37432709",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.33029/0042-8833-2023-92-3-69-78"
}
},
{
"@type": "ScholarlyArticle",
"name": "Phthalates and bone mineral density: a systematic review.",
"datePublished": "2022-11-12",
"url": "https://questionsmedicales.fr/article/36369032",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12940-022-00920-5"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Hémopathies et maladies lymphatiques",
"item": "https://questionsmedicales.fr/mesh/D006425"
},
{
"@type": "ListItem",
"position": 3,
"name": "Hémopathies",
"item": "https://questionsmedicales.fr/mesh/D006402"
},
{
"@type": "ListItem",
"position": 4,
"name": "Maladies de la moelle osseuse",
"item": "https://questionsmedicales.fr/mesh/D001855"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Maladies de la moelle osseuse - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Maladies de la moelle osseuse",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-04-29",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Maladies de la moelle osseuse",
"description": "Comment diagnostiquer une maladie de la moelle osseuse ?\nQuels tests sont utilisés pour évaluer la moelle osseuse ?\nQuels signes indiquent une maladie de la moelle osseuse ?\nQuelle imagerie est utilisée pour la moelle osseuse ?\nLes tests sanguins peuvent-ils détecter des maladies de la moelle ?",
"url": "https://questionsmedicales.fr/mesh/D001855?mesh_terms=Bone+Density#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Maladies de la moelle osseuse",
"description": "Quels sont les symptômes courants des maladies de la moelle osseuse ?\nComment la moelle osseuse affecte-t-elle le système immunitaire ?\nLes maladies de la moelle osseuse causent-elles des saignements ?\nPeut-on avoir des douleurs osseuses avec ces maladies ?\nLes symptômes varient-ils selon le type de maladie ?",
"url": "https://questionsmedicales.fr/mesh/D001855?mesh_terms=Bone+Density#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Maladies de la moelle osseuse",
"description": "Peut-on prévenir les maladies de la moelle osseuse ?\nQuels facteurs de risque sont évitables ?\nL'alimentation joue-t-elle un rôle dans la prévention ?\nLe tabagisme influence-t-il les maladies de la moelle ?\nLes examens réguliers aident-ils à la prévention ?",
"url": "https://questionsmedicales.fr/mesh/D001855?mesh_terms=Bone+Density#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Maladies de la moelle osseuse",
"description": "Quels traitements sont disponibles pour les maladies de la moelle osseuse ?\nLa greffe de moelle osseuse est-elle efficace ?\nQuels médicaments sont utilisés pour traiter ces maladies ?\nLa radiothérapie est-elle une option de traitement ?\nLes traitements sont-ils personnalisés ?",
"url": "https://questionsmedicales.fr/mesh/D001855?mesh_terms=Bone+Density#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Maladies de la moelle osseuse",
"description": "Quelles complications peuvent survenir avec ces maladies ?\nLes maladies de la moelle osseuse augmentent-elles le risque de cancer ?\nComment les infections sont-elles liées à ces maladies ?\nLes saignements peuvent-ils être graves ?\nQuelles sont les conséquences d'une insuffisance médullaire ?",
"url": "https://questionsmedicales.fr/mesh/D001855?mesh_terms=Bone+Density#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Maladies de la moelle osseuse",
"description": "Quels sont les principaux facteurs de risque ?\nL'âge influence-t-il le risque de maladies de la moelle ?\nLes maladies auto-immunes sont-elles un facteur de risque ?\nLe mode de vie peut-il affecter le risque ?\nLes infections virales sont-elles un facteur de risque ?",
"url": "https://questionsmedicales.fr/mesh/D001855?mesh_terms=Bone+Density#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une maladie de la moelle osseuse ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic se fait par des analyses sanguines, biopsies et examens d'imagerie."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer la moelle osseuse ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent l'aspiration de moelle osseuse et des tests génétiques."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une maladie de la moelle osseuse ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes incluent fatigue, infections fréquentes et saignements anormaux."
}
},
{
"@type": "Question",
"name": "Quelle imagerie est utilisée pour la moelle osseuse ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'IRM et la tomodensitométrie sont souvent utilisées pour visualiser la moelle."
}
},
{
"@type": "Question",
"name": "Les tests sanguins peuvent-ils détecter des maladies de la moelle ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des tests sanguins peuvent révéler des anomalies dans les cellules sanguines."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants des maladies de la moelle osseuse ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fatigue, fièvre, ecchymoses et douleurs osseuses."
}
},
{
"@type": "Question",
"name": "Comment la moelle osseuse affecte-t-elle le système immunitaire ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une moelle osseuse malade peut réduire la production de globules blancs, affaiblissant l'immunité."
}
},
{
"@type": "Question",
"name": "Les maladies de la moelle osseuse causent-elles des saignements ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent entraîner des saignements excessifs en raison d'une faible production de plaquettes."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des douleurs osseuses avec ces maladies ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des douleurs osseuses peuvent survenir en raison de l'infiltration de cellules anormales."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le type de maladie ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier selon le type de maladie de la moelle osseuse."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les maladies de la moelle osseuse ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines maladies sont héréditaires, mais un mode de vie sain peut réduire les risques."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque sont évitables ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter l'exposition à des produits chimiques toxiques peut réduire le risque."
}
},
{
"@type": "Question",
"name": "L'alimentation joue-t-elle un rôle dans la prévention ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée peut soutenir la santé de la moelle osseuse et du sang."
}
},
{
"@type": "Question",
"name": "Le tabagisme influence-t-il les maladies de la moelle ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme est un facteur de risque pour plusieurs maladies hématologiques."
}
},
{
"@type": "Question",
"name": "Les examens réguliers aident-ils à la prévention ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des examens réguliers peuvent aider à détecter précocement des anomalies."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour les maladies de la moelle osseuse ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent chimiothérapie, radiothérapie et greffe de moelle osseuse."
}
},
{
"@type": "Question",
"name": "La greffe de moelle osseuse est-elle efficace ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut être curative pour certaines maladies, mais comporte des risques."
}
},
{
"@type": "Question",
"name": "Quels médicaments sont utilisés pour traiter ces maladies ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments comme les agents immunosuppresseurs et les facteurs de croissance sont utilisés."
}
},
{
"@type": "Question",
"name": "La radiothérapie est-elle une option de traitement ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la radiothérapie peut être utilisée pour traiter certaines formes de cancer de la moelle."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils personnalisés ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements sont souvent adaptés en fonction du type et de la gravité de la maladie."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec ces maladies ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent infections, saignements et insuffisance médullaire."
}
},
{
"@type": "Question",
"name": "Les maladies de la moelle osseuse augmentent-elles le risque de cancer ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines maladies de la moelle osseuse peuvent augmenter le risque de cancers secondaires."
}
},
{
"@type": "Question",
"name": "Comment les infections sont-elles liées à ces maladies ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une moelle osseuse défaillante peut entraîner une immunodéficience, augmentant le risque d'infections."
}
},
{
"@type": "Question",
"name": "Les saignements peuvent-ils être graves ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des saignements graves peuvent survenir en raison d'une faible production de plaquettes."
}
},
{
"@type": "Question",
"name": "Quelles sont les conséquences d'une insuffisance médullaire ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'insuffisance médullaire peut entraîner une anémie sévère, des infections et des hémorragies."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'exposition à des radiations, des produits chimiques et des antécédents familiaux."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque de maladies de la moelle ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque augmente avec l'âge, surtout après 60 ans."
}
},
{
"@type": "Question",
"name": "Les maladies auto-immunes sont-elles un facteur de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines maladies auto-immunes peuvent augmenter le risque de troubles de la moelle osseuse."
}
},
{
"@type": "Question",
"name": "Le mode de vie peut-il affecter le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des habitudes comme le tabagisme et une mauvaise alimentation peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "Les infections virales sont-elles un facteur de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines infections virales, comme le VIH, peuvent augmenter le risque de maladies de la moelle."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 10/04/2025
Contenu vérifié selon les dernières recommandations médicales
└─
Aplasies médullaires
Bone Marrow Failure Disorders
D000080983
-
C15.378.190.223
└─
Maladies myélodysplasiques-myéloprolifératives
Myelodysplastic-Myeloproliferative Diseases
D054437
-
C15.378.190.615
└─
Syndromes myélodysplasiques
Myelodysplastic Syndromes
D009190
-
C15.378.190.625
└─
Syndromes myéloprolifératifs
Myeloproliferative Disorders
D009196
-
C15.378.190.636
└─└─
Anémie aplasique
Anemia, Aplastic
D000741
-
C15.378.190.223.250
└─└─
Leucémie myélomonocytaire juvénile
Leukemia, Myelomonocytic, Juvenile
D054429
-
C15.378.190.615.520
└─└─
Anémie réfractaire
Anemia, Refractory
D000753
-
C15.378.190.625.062
└─└─
Anémie sidéroblastique
Anemia, Sideroblastic
D000756
-
C15.378.190.625.070
└─└─
Hémoglobinurie paroxystique
Hemoglobinuria, Paroxysmal
D006457
-
C15.378.190.625.460
└─└─
Anémie myélophtisique
Anemia, Myelophthisic
D000750
-
C15.378.190.636.085
└─└─
Leucémie érythroblastique aigüe
Leukemia, Erythroblastic, Acute
D004915
-
C15.378.190.636.276
└─└─
Myélofibrose primitive
Primary Myelofibrosis
D055728
-
C15.378.190.636.765
└─└─
Thrombocytose
Thrombocytosis
D013922
-
C15.378.190.636.860
└─└─└─
Anémie réfractaire avec excès de blastes
Anemia, Refractory, with Excess of Blasts
D000754
-
C15.378.190.625.062.080
2 publications dans cette catégorie
Affiliations :
Division of Pediatric Radiology, Department of Radiology, University Medical Center Freiburg, University of Freiburg, Freiburg, Germany.
Publications dans "Maladies de la moelle osseuse" :
2 publications dans cette catégorie
Affiliations :
Division of Pediatric Hematology and Oncology, Department of Pediatric and Adolescent Medicine, University Medical Center Freiburg, University of Freiburg, Freiburg, Germany.
Publications dans "Maladies de la moelle osseuse" :
2 publications dans cette catégorie
Affiliations :
Institute for Clinical Chemistry and Laboratory Medicine, University Hospital and Faculty of Medicine Carl Gustav Carus of TU Dresden, Germany (I.M., T.C.).
National Center for Tumor Diseases (NCT), Partner Site Dresden, German Cancer Research Center (DKFZ), Heidelberg, Germany (I.M.).
First Department of Internal Medicine, Department of Haematology and Laboratory of Molecular Hematology, Democritus University of Thrace, Alexandroupolis, Greece (I.M.).
Publications dans "Maladies de la moelle osseuse" :
2 publications dans cette catégorie
Affiliations :
Laboratory of Innate Immunity and Inflammation, Department of Basic and Translational Sciences, Penn Dental Medicine, University of Pennsylvania, Philadelphia (G.H.).
Publications dans "Maladies de la moelle osseuse" :
2 publications dans cette catégorie
Affiliations :
Institute for Clinical Chemistry and Laboratory Medicine, University Hospital and Faculty of Medicine Carl Gustav Carus of TU Dresden, Germany (I.M., T.C.).
Centre for Cardiovascular Science, Queen's Medical Research Institute, University of Edinburgh, United Kingdom (T.C.).
Publications dans "Maladies de la moelle osseuse" :
2 publications dans cette catégorie
Affiliations :
Bone Vascular and Microcirculation Laboratory, Department of Kinesiology, University of Texas at Arlington, Arlington, Texas, USA.
Publications dans "Maladies de la moelle osseuse" :
2 publications dans cette catégorie
Publications dans "Maladies de la moelle osseuse" :
2 publications dans cette catégorie
Publications dans "Maladies de la moelle osseuse" :
2 publications dans cette catégorie
Affiliations :
Mayo Clinic Rochester, MN, USA.
Publications dans "Maladies de la moelle osseuse" :
2 publications dans cette catégorie
Publications dans "Maladies de la moelle osseuse" :
2 publications dans cette catégorie
Publications dans "Maladies de la moelle osseuse" :
1 publication dans cette catégorie
Affiliations :
Department of Radiology, Te Toka Tumai Auckland (Auckland District Health Board), Grafton, Auckland, New Zealand.
Department of Anatomy and Medical Imaging, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
Department of Radiology, IMSKE, València, Spain.
Publications dans "Maladies de la moelle osseuse" :
1 publication dans cette catégorie
Affiliations :
Diagnostic and Interventional Radiology, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.
Publications dans "Maladies de la moelle osseuse" :
1 publication dans cette catégorie
Affiliations :
Tissue and Tumor Microenvironments Group, The Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK.
Publications dans "Maladies de la moelle osseuse" :
1 publication dans cette catégorie
Affiliations :
Institute of Clinical Sciences, Imperial College London, London, UK.
MRC London Institute of Medical Sciences, Imperial College London, London, UK.
Publications dans "Maladies de la moelle osseuse" :
1 publication dans cette catégorie
Affiliations :
Tissue and Tumor Microenvironments Group, The Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK.
Publications dans "Maladies de la moelle osseuse" :
1 publication dans cette catégorie
Affiliations :
Institute of Clinical Sciences, Imperial College London, London, UK.
MRC London Institute of Medical Sciences, Imperial College London, London, UK.
Publications dans "Maladies de la moelle osseuse" :
1 publication dans cette catégorie
Affiliations :
Tissue and Tumor Microenvironments Group, The Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK.
Publications dans "Maladies de la moelle osseuse" :
1 publication dans cette catégorie
Affiliations :
Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Jagtvej 160, Copenhagen Ø DK-2100, Denmark; Sheffield Myeloma Research Team, Department of Oncology and Metabolism, Medical School, University of Sheffield, Beech Hill Road, Sheffield S10 2RX, UK; Mellanby Centre for Bone Research, University of Sheffield Medical School, University of Sheffield, Beech Hill Road, Sheffield S10 2RX, UK; Department of Haematology, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Glossop Road, Sheffield S10 2JF, UK. Electronic address: marta.castillo@sund.ku.dk.
Publications dans "Maladies de la moelle osseuse" :
1 publication dans cette catégorie
Affiliations :
Sheffield Myeloma Research Team, Department of Oncology and Metabolism, Medical School, University of Sheffield, Beech Hill Road, Sheffield S10 2RX, UK; Mellanby Centre for Bone Research, University of Sheffield Medical School, University of Sheffield, Beech Hill Road, Sheffield S10 2RX, UK; Department of Haematology, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Glossop Road, Sheffield S10 2JF, UK.
Publications dans "Maladies de la moelle osseuse" :
Childhood and adolescence are critical periods of bone mineral acquisition. Children on anticoagulation (AC) might have an increased risk for reduced bone mineral density (BMD). Risk factors for impai...
To evaluate BMD in children on AC and characterize the risk factors of low BMD, including VK and Vitamin D (VD) status....
Single-center cross-sectional study of clinical, biochemical, and densitometric parameters. Assessment of VK surrogate parameters included ucOC and matrix gla protein (MGP)....
A total of 39 children (4-18 years; 12 females) receiving AC were included, 31 (79%) on VK antagonists and 8 (21%) on direct oral anticoagulants. Overall, BMD was decreased for both the lumbar spine (...
Our data indicate BMD reduction in pediatric patients on AC. Although AC-related factors did not predict reduced BMD, low BMI and pubertal stages represented important risk factors. Awareness of risk ...
This study evaluated the intraoperative physician assessment (IPA) of bone status at time of total knee arthroplasty. IPA was highly correlated with distal femur and overall bone mineral density. When...
Intuitively, intraoperative physician assessment (IPA) would be an excellent measure of bone status gained through haptic feedback during bone preparation. However, no studies have evaluated the ortho...
Seventy patients undergoing TKA by 3 surgeons received pre-operative DXA. Intraoperatively, bone quality was assessed on a 5-point scale (1 excellent to 5 poor) based on tactile feedback to preparatio...
The mean (SD) age and BMI were 65.8 (7.6) years and 31.4 (5.1) kg/m...
IPA is highly correlated with local (distal femur) and overall BMD. This study supports the International Society for Clinical Densitometry position that surgeon concern regarding bone quality should ...
Osteoporosis is a common disease that leads to a reduction in bone density and increases the risk of fractures. Stable surgical treatment is particularly important for these fractures. The aim of this...
The number of vegetarians and vegans is increasing each year. In this regard, studies of the quality of diets that exclude slaughter foods, as well as their impact on human health, are becoming more a...
Exposure to endocrine disruptors, such as phthalates, may impact bone mineral density (BMD) through a variety of mechanisms. Studies of phthalate exposure and BMD in humans are scarce....
To synthesize published data on the association between phthalate metabolites and BMD in humans and to provide methodological suggestions for future research....
A single investigator searched PubMed for relevant studies, including observational studies of phthalate exposure and BMD in children and postmenopausal women. Twelve studies were screened with 5 meet...
In one prospective study among postmenopausal women, higher levels of monocarboxyoctyl phthalate (MCOP) and monocarboxynonyl phthalate (MCNP) were significantly associated with lower BMD among nonuser...
Studies among postmenopausal women provide suggestive evidence of an association between urinary phthalate metabolite concentration and decreased BMD. Results from studies of childhood BMD are inconcl...
Sagittal spinal malalignment often leads to surgical realignment, which is associated with major complications. Low bone mineral density (BMD) and impaired bone microstructure are risk factors for ins...
A retrospective, cross-sectional study of patients who underwent lumbar fusion for degeneration was conducted. The vBMD of the lumbar spine was assessed by quantitative computed tomography. Bone biops...
A total of 172 patients (55.8% female, 63.3 years, BMI 29.7 kg/m...
Sagittal malalignment is associated with lower lumbar vBMD and trabecular microstructure. Lumbar vBMD was significantly lower in patients with malalignment. These findings warrant attention, as malali...
The aims of the study were to determine the mean trabecular bone score (TBS) of postmenopausal Taiwanese women and to analyze the value of TBS in predicting osteoporosis....
A total of 1,915 postmenopausal women with lumbar spine and hip bone mineral density (BMD) and spine TBS were enrolled from a single medical center into this study. The women's BMD and TBS were measur...
The average age of the women was 62.5 ± 9.1 years (range, 25.7-93.7 years). The mean TBS was 1.300 ± 0.086 (range, 1.015-1.596). The TBS was weakly and negatively correlated with body mass index ( r =...
Bone mineral density and TBS can be used in combination to predict osteoporosis in a greater number of postmenopausal Taiwanese women. Because the incidence of osteoporosis is the highest among older ...
Children with haemophilia (CwH) have lower bone mineral density in the spine (trabecular bone) than healthy children. There are few studies focusing on bone mineral density in long bones (cortical bon...
To evaluate bi-laterally the distal third of radius and midshaft tibias using quantitative ultrasound (QUS) and assess the speed of sound (SoS)....
A cross-sectional study where 91 CwH and 91 age-matched healthy boys were included. Joint evaluation was determined with the Haemophilia Joint Health Score 2.1 and SoS values. The Z scores were measur...
Ninety-one CwH (haemophilia A) were evaluated (26 mild form, 26 moderate, and 39 severe). Most patients were treated with on-demand factor replacement and had higher total HJHS scores according to sev...
There was diminished cortical bone density in radius and tibias of CwH compared to healthy controls. Changes predominated in tibias, more frequently affected according to the severity of haemophilia. ...
Low bone mineral density (BMD) and dementia commonly co-occur in older individuals, with bone loss accelerating in patients with dementia due to physical inactivity and poor nutrition. However, uncert...
In a prospective population-based cohort study, BMD at the femoral neck, lumbar spine, and total body and the trabecular bone score (TBS) were obtained using dual-energy X-ray absorptiometry in 3,651 ...
Among the 3,651 participants (median age 72.3 ± 10.0 years, 57.9% women), 688 (18.8%) developed incident dementia during a median of 11.1 years, of whom 528 (76.7%) developed Alzheimer disease (AD). D...
In conclusion, participants with low femoral neck and total body BMD and low TBS were more likely to develop dementia. Further studies should focus on the predictive ability of BMD for dementia....
Bone health in primary ovarian insufficiency (POI) is under-investigated. We assessed patients with spontaneous POI for vertebral fractures (VFs) and related parameters of bone health....
70 cases with spontaneous POI (age 32.5 ± 7.0 years) and an equal number of controls were assessed for BMD, TBS, and VFs. BMD at the lumbar-spine (L1-L4), left hip, non-dominant forearm, and TBS (iNsi...
BMD at the lumbar-spine, hip and forearm was reduced by 11.5%, 11.4% and 9.1% in POI as compared to controls (P < 0.001). Degraded or partially degraded microarchitecture on TBS was observed in 66.7% ...
Thus, lumbar-spine osteoporosis, impaired TBS and VFs were present in 35.7%, 66.7% and 15.7% of patients with spontaneous POI in their early third decade. This indicates need for rigorous investigatio...